pharma · Atopic Dermatitis Eczema · Plaque Psoriasis · ARQT
Arcutis Biotherapeutics
Arcutis Biotherapeutics trial registry — 28 ClinicalTrials.gov studies with program phase, status, and indication context.
2945 Townsgate Rd, Westlake Village, California 91361, US HQ
2016 Founded
427 Employees
Public company Type
ARQT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2945 Townsgate Rd, Westlake Village, California 91361, US
- Founded
- 2016
- Employees
- 427
- Programs
- 27
- Drugs
- 3
- Patents
- 30
Arcutis Biotherapeutics clinical trials
Registry index of 28 ClinicalTrials.gov studies linked to Arcutis Biotherapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Arcutis Biotherapeutics trial registry — 28 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Arcutis Biotherapeutics.
-
Topical roflumilast — Phase 3
Clinical update -
Topical roflumilast 0.3% foam — Phase 2
Clinical update -
Roflumilast Cream 0.15% — Approved
Clinical update -
ARQ-151 0.3% cream — Phase 3
Clinical update -
ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05% — Phase 3
Clinical update -
Roflumilast 0.3% cream — Phase 3
Clinical update -
Roflumilast Cream — Phase 3
Clinical update -
Roflumilast Cream 0.05% — Phase 3
Clinical update